Apimeds Pharmaceuticals Us (APUS) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Apimeds Pharmaceuticals US, Inc.  (NYSE: APUS)

Apimeds Pharmaceuticals Us Profitability Comparisons

Select each Category to receive further Information




APUS Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 68.81 % 54.17 % 38.76 %
Gross Margin (Q2 TTM) - 68.6 % 55.57 % 38.04 %
Gross Profit Margin 5 Yr. Avg. - 54.59 % 50.07 % 26.86 %
EBITDA Margin (Q2 MRQ) - 22.25 % 19.62 % 20.72 %
EBITDA Margin (Q2 TTM) - 25.29 % 21.02 % 19.28 %
EBITDA Margin 5 Yr. Avg. - 22.39 % 18.02 % 11.22 %
Operating Margin (Q2 MRQ) - 17.27 % 16.57 % 16.03 %
Operating Margin (Q2 TTM) - 20.31 % 17.93 % 16.33 %
Operating Margin 5 Yr. Avg. - 18.61 % 12.02 % 8.17 %
Pre-Tax Profit Margin (Q2 MRQ) - 13.66 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) - 16.69 % 12.85 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 21.15 % 12.23 % 8.22 %
Net Margin (Q2 MRQ) - 10.09 % 8.14 % 11.41 %
Net Margin (Q2 TTM) - 13.14 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. - 15.99 % 7.98 % 6.23 %



Business Segment Profit Margin
 
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) - 14.7 % 13.26 % 9.53 %
Free Cash Flow Margin (Q2 TTM) - 17.25 % 14.06 % 9.26 %
Free Cash Flow Margin 5 Yr. Avg. - 22.22 % 13.86 % 8.26 %
Net Cash Flow Margin (Q2 MRQ) - -1.43 % 1.7 % 2.36 %
Net Cash Flow Margin (Q2 TTM) - -0.76 % 0.09 % 1.79 %
Net Cash Flow Margin 5 Yr. Avg. - 0.26 % 1.42 % 1.41 %
Effective Tax Rate (Q2 MRQ) - 25.98 % 25.41 % 18.85 %
Effective Tax Rate (Q2 TTM)